Toxicology - Exam 1 (CVD, Lipids, Anti-clotting drugs)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/75

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:32 PM on 8/11/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

76 Terms

1
New cards

Hypertension

>130mmHg or >80mmHg

2
New cards

Antihypertensives lower BP via three ways

sympathetic NS signaling to head, vasculature, kidneys (sympatholytics)

RAAS or directly on kidney (diuretics, ACE inhibitors, ARBs)

smooth muscle of vasculature (calcium channel blockers)

3
New cards

Drugs for heart failure

sympatholytics

diuretics

ACE inhibitors

ARBs

vasodilators (NOT calcium channel blockers)

4
New cards

MC drug used for angina

antianginals - nitrates, calcium blockers, beta-blockers

5
New cards

Sympatholytics are used in

HTN, CHF, Angina

6
New cards

Diuretics are used in

HTN and CHF

7
New cards

ACE inhibitors are used in

HTN and CHF

8
New cards

Angiotension receptor antagonists (ARBs) are used in

HTN and CHF

9
New cards

Vasodilators are used in

HTN, CHF, Angina

10
New cards

Sympatholytics (adrenergic receptor antagonists)

Epi/NE blockers

MC prescribed block beta adrenergic receptors (beta-blockers)

11
New cards

Normal physiology - Beta-1 (heart and kidney)

stimulation produces cardiac stimulation (inc HR, contractility, conduction velocity)

increase renin secretion from juxtaglomerular cells

12
New cards

Normal physiology - Beta-2 (smooth muscle)

stimulation relaxes bronchial, uterine, peripheral vascular smooth muscle

mediates glycogenolysis in liver to increase blood glucose

13
New cards

Beta-1 antagonists

block renin secretion

leads to decrease in CO (HR and contractility), HR, BV = decrease BP

14
New cards

Beta blockers in CHF

decrease sympathetic stimulation

decrease energy demands on heart

decrease stimulation of RAAS

15
New cards

Beta blockers in Angina

decrease HR, BP, contractility

prevent coronary vasospasm (vasodilation to dec pressure)

16
New cards

Two types of beta-blockers

non-selective beta blockers

selective beta blockers

17
New cards

Non-selective beta blockers

block BOTH receptor types 1+2

more side effects

18
New cards

Adverse effects of non-selective beta blockers

bronchoconstriction in asthmatics and COPD

peripheral vasoconstriction in Raynaud’s

diabetics inhibit epi stimulated glycogenolysis in liver

19
New cards

Selective beta blockers

block ONLY Beta-1 receptors

cardio selective = preferred use in HTN, CHF, angina, arrhythmias

20
New cards

Adverse effects of all beta blockers

hypotension and bradycardia

fatigue and insomnia

erectile dysfunction

inc triglycerides and dec HDL cholesterol

21
New cards

TQ = T/F Do NOT abruptly discontinue tx with these drugs (lead to MI or sudden death in pt with ischemic heart disease)

True

22
New cards

Interactions of all beta blockers

NSAIDs - decrease effectiveness

herbs and supplements used for lowering BP or anti-diabetic

  • elevated risk for hypoglycemia

23
New cards

Nutrient depletions of all beta blockers

CoQ10

melatonin

24
New cards

Beta blocker names

End in -olol (propranolol, atenolol, metaoprolol (MC), nebivolol, caredilol)

25
New cards

Diuretics

reduce blood volume which decreases CO and eventually peripheral vascular resistance

prevents reabsorption of sodium (water follows sodium excretion)

lowers BP by 10-15mmHg

26
New cards

Types of Diuretics

Thiazides (distal convoluted tubule)

Loop (loop of henle)

Potassium-sparing (collecting duct)

27
New cards

Thiazides clinical uses

HTN, CHF, osteoporosis

28
New cards

Thiazides names

End in -ide (hydrochlorthiazide, indapamide)

29
New cards

Adverse effects of thiazides and loop diuretics

hypokalemia, hyponatremia, hypomagnesemia

hyperuricemia and hyperglycemia

allergic reactions

30
New cards

Drug/herb interactions of thiazides and loop diuretics

NSAIDs - diminish effects of drugs

anthroquinone glycoside laxitives - electrolyte disturbances

glycyrrhiza glabra

taraxacum

31
New cards

Nutrient depletions of thiazides and loop diuretics

potassium, sodium, magnesium

zinc

vitamins C, B1, B6

32
New cards

Nutrient depletions via thiazides only

CoQ10

33
New cards

Loop diuretics clinical uses

intensive diuresis in CHF, acute hypercalcemia, tx resistant HTN

34
New cards

Loop diuretic names (Lasix)

End in -ide (furosemide, bumetanide)

35
New cards

Adverse effects of Loop diuretics

hypocalcemia and ototoxicity (reversible hearing loss)

36
New cards

Nutrient depletions caused by only loop diuretics

calcium

37
New cards

Potassium-sparing diuretics

function on sodium transporters that are affected by aldosterone

they block them causing sodium excretion and potassium retention

38
New cards

Potassium-sparing diuretics clinical uses

HTN and CHF and Conn’s syndrome (secondary hyperaldosteronism)

39
New cards

Potassium-sparing diurteic names

Spironolactone, amiloride, triamterene

40
New cards

Spironolactone (potassium-sparing diuretic)

aldosterone analog and receptor antagonist

also used as androgen blocker for PCOS/PMOS

41
New cards

Adverse effects of potassium-sparing diuretics

hyperkalemia

androgen blocking effects

acute renal failure

trimeterene can cause kidney stones

42
New cards

Drug/herb interactions with potassium-sparing diuretics

potassium supplements and diet rich in potassium

triamterene w/indomethacin = acute renal failure

43
New cards

Nutrient depletions from potassium-sparing diuretics

amiloride = folic acid and calcium

triamterne = folic acid, calcium, zinc

44
New cards

ACE inhibitors

blocks formation of vasoconstrictor angiotensin II

blocks degradation of vasodilator bradykinin

45
New cards

ACE inhibitor names

End in -pril (lisinopril, captopril, enalapril)

46
New cards

Clinical uses for ACE inhibitors

HTN, CHF, post-MI, diabetics

47
New cards

Adverse effects of ACE inhibitors

cough (w/inc bradykinin levels)

taste change (drug binds to zinc)

pregnancy problems (fetal death in 2/3tri)

48
New cards

Drug/herb interactions of ACE inhibitors + ARBs

antacids

potassium-sparing diuretics

NSAIDs

49
New cards

Nutrient depletion from ACE inhibitors + ARBs

zinc

50
New cards

Angiotension Receptor Antagonists (ARBs)

block angiotension receptors in vascular smooth muscle and adrenal cortex

causes vasodilation and decreased aldosterone secretion

inhibits angiotension action MORE than ACE inhibitors and don’t inhibit bradykinin

  • pts don’t cough

51
New cards

ARBs names

End in -sartan (losartan, valsartan, olmesartan, irbesartan)

52
New cards

Clinical uses for ARBs

HTN, CHF, post-MI

53
New cards

Adverse effects of ARBs

pregnancy problems (fetal death in 2/3tri)

54
New cards

Vasodilators (Calcium channel blockers)

relax smooth muscle of arterioles (decrease systemic resistance) = decrease BP

inhibit calcium flow into smooth and cardiac muscle cells = decrease contraction

55
New cards

Clinical uses of calcium channel blockers

HTN, angina, arrhythmias

56
New cards

Calcium channel blockers names

End in -pine (amlodipine, felodipine, nifedipine, verapamil, diltiazem)

57
New cards

Adverse effects of calcium channel blockers

suppress cardiac contractility (contraindicated in CHF pts)

hyptension/syncope

(MC) peripheral edema

58
New cards

Drug/herb interactions with calcium channel blockers

melatonin

increase statin levels (if taking with)

grapefruit juice

59
New cards

What is the ONLY drug class that NSAIDs don’t impact

vasodilators - calcium channel blockers

60
New cards

Positive inotropes (Digoxin)

used in CHF and arrhythmias

increase force of heart contraction (directly inhibit Na/ATPase in cardiac myocytes)

narrow therapeutic window + long half-live = easy to overdose

61
New cards

Potassium channel blockers are used in

CHF and arrhythmias

62
New cards

8 ways drugs are used to lower blood lipids

statins - decrease cholesterol production by liver

ezetimibe - prevent absorption of dietary cholesterol

PCSK9 inhibitors - increase LDL receptors in liver

lipoprotein a lowering drugs

bile acid binding proteins - prevent enterohepatic recycling of bile acids

fibrates - affect transcription of genes associated w/lipid metabolism

niacin - decrease release of FFAs from adipose tissue

EPA/DHA fatty acid esters (fish oil) - dec production of triglycerides

63
New cards

HMG-CoA Reductase Inhibitors (statins)

End in -statin (lovastatin/parent compound, atorvastatin (MC), simvastatin, rosuvastatin)

64
New cards

HMG-CoA Reductase inhibitors characteristics

competitive inhibitors or rate limiting step in cholesterol biosynthesis

65
New cards

HMG-CoA Reductase enzyme job

converts HMG-CoA → melavonate

66
New cards

HMG-CoA Reductase inhibitors reduce ____ causing

hepatic cholesterol synthesis and serum levels; increased expression of LDL receptors on liver (cholesterol is pulled from periphery)

67
New cards

What may be a risk factor when taking HMG-CoA Reductase inhibitors

insulin resistance

68
New cards

HMG-CoA Reductase inhibitors clinical use

hypercholesterolemia

mixed hyperlipidemia

slow progression of atherosclerosis

69
New cards

HMG-CoA Reductase inhibitors adverse effects

elevate serum hepatic enzymes → hepatitis

myalgia, rhabdomyolysis, acute renal failure

70
New cards

Individuals can take ____ to decrease the risk of muscle issues while using HMG-CoA Reductase inhibitors

CoQ10

71
New cards

Interactions with HMG-CoA Reductase inhibitors

fibrates + lots of niacin (inc myopathies)

drugs metabolized by CYP3A4 (inc serum levels)

grapefruit juice (inc serum levels)

red yeast rice (acts as a statin too)

72
New cards

Contraindications to taking HMG-CoA Reductase inhibitors

pregnancy (fetal abnormalities)

73
New cards

Nutrient depletions with HMG-CoA Reductase inhibitors

CoQ10 (at least 100mg/d)

74
New cards

L-Arginine relationship with HMG-CoA Reductase inhibitors

co-administration can enhance triglyceride-lowering effect

75
New cards

Vitamin D relationship with HMG-CoA Reductase inhibitors

deficiency can increase risk of myalgia

76
New cards

LDL targets for high